Stability of osteopontin in plasma and serum

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 11, 2012, Pages 1979-1984

  Lanteri, Patrizia ^a   Lombardi, Giovanni ^a   Colombini, Alessandra ^a   Grasso, Dalila ^a   Banfi, Giuseppe ^a,b  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Immunodetection; Osteopontin; Pre analytical phase; Stability

Indexed keywords

OSTEOPONTIN;

ARTICLE; ENZYME IMMUNOASSAY; ENZYMOIMMUNOMETRIC ASSAY; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; ROOM TEMPERATURE; STORAGE TEMPERATURE; WESTERN BLOTTING;

ANTIBODY SPECIFICITY; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; BLOTTING, WESTERN; DRUG STABILITY; DRUG STORAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; OSTEOPONTIN; PLASMA; PROTEIN ISOFORMS; SERUM; TEMPERATURE; TIME FACTORS;

EID: 84872915288     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0177     Document Type: Article

References (27)

1. Sennels HP, Jacobsen S, Jensen T, Hansen MS, Ostergaard M, Nielsen HJ, et al. Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein. Scand J Clin Lab Invest 2007;67:821 - 35.
2. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007;27:2302 - 9.
3. Kazanecki CC, Uzwiak DJ, Denhardt DT. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 2007;102:912 - 24.
4. Kasugai S, Zhang Q, Overall CM, Wrana JL, Butler WT, Sodek J. Differential regulation of the 55 and 44 kDa forms of secreted phosphoprotein 1 (SPP-1, osteopontin) in normal and transformed rat bone cells by osteotropic hormones, growth factors and a tumor promoter. Bone Miner 1991;13:235 - 50.
5. Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med 2000;11:279 - 303.
6. Chellaiah MA, Hruska KA. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int 2003;72:197 - 205.
7. Yoo KH, Thornhill BA, Forbes MS, Coleman CM, Marcinko ES, Liaw L, et al. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int 2006;70:1735 - 41.
8. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994;74:214 - 24.
9. Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, Liaw L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem 2001;276:28261 - 7.
10. Kaartinen MT, El-Maadawy S, Rasanen NH, McKee MD. Tissue transglutaminase and its substrates in bone. J Bone Miner Res 2002;17:2161 - 73.
11. Nishimichi N, Higashikawa F, Kinoh HH, Tateishi Y, Matsuda H, Yokosaki Y. Polymeric osteopontin employs integrin alpha9-beta1 as a receptor and attracts neutrophils by presenting a de novo binding site. J Biol Chem 2009;284:14769 - 76.
12. Nishimichi N, Hayashita-Kinoh H, Chen C, Matsuda H, Sheppard D, Yokosaki Y. Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1. J Biol Chem 2011;286:11170 - 8.
13. Denhardt DT, Noda M, O ' Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055 - 61.
14. Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 1994;5:565 - 74.
15. O ' Regan A, Berman JS. Osteopontin: a key cytokine in cellmediated and granulomatous inflammation. Int J Exp Pathol 2000;81:373 - 90.
16. Smith LL, Giachelli CM. Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin. Exp Cell Res 1998;242:351 - 60.
17. Hasegawa M, Nakoshi Y, Iino T, Sudo A, Segawa T, Maeda M, et al. Thrombin-cleaved osteopontin in synovial fluid of subjects with rheumatoid arthritis. J Rheumatol 2009;36:240 - 5.
18. Senger DR, Perruzzi CA, Gracey CF, Papadopoulos A, Tenen DG. Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res 1988;48:5770 - 4.
19. Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, et al. Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma. Int J Biol Markers 2010;25:164 - 70.
20. Simundic AM, Nikolac N, Vukasovic I, Vrkic N. The prevalence of preanalytical errors in a Croatian ISO 15189 accredited laboratory. Clin Chem Lab Med 2010;48:1009 - 14.
21. Hollensead SC, Lockwood WB, Elin RJ. Errors in pathology and laboratory medicine: consequences and prevention. J Surg Oncol 2004;88:161 - 81.
22. Howanitz PJ. Errors in laboratory medicine: practical lessons to improve patient safety. Arch Pathol Lab Med 2005;129:1252 - 61.
23. Lippi G, Salvagno GL, Montagnana M, Poli G, Guidi GC. Influence of centrifuge temperature on routine coagulation testing. Clin Chem 2006;52:537 - 8.
24. Lombardi G, Lanteri P, Colombini A, BanfiG. Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling. Clin Chem Lab Med 2012;50:771-89.
25. BanfiG, Dolci A. Preanalytical phase of sport biochemistry and haematology. J Sports Med Phys Fitness 2003;43:223 - 30.
26. Yamaguchi Y, Hanashima S, Yagi H, Takahashi Y, Sasakawa H, Kurimoto E, et al. NMR characterization of intramolecular interaction of osteopontin, an intrinsically disordered protein with cryptic integrin-binding motifs. Biochem Biophys Res Commun 2010;393:487 - 91.
27. Kaartinen MT, Pirhonen A, Linnala-Kankkunen A, Maenpaa PH. Transglutaminase-catalyzed cross-linking of osteopontin is inhibited by osteocalcin. J Biol Chem 1997;272:22736 - 41.